Related Experiment Videos
Overview of chemotherapy-induced diarrhea
1Department of Nursing, University of California at San Francisco, 505 Parnassus Dr, San Francisco, CA 94143, USA.
Seminars in Oncology Nursing
|January 2, 2004
Summary
Chemotherapy-induced diarrhea (CID) frequently impacts patient quality of life and treatment costs. Oncology nurses play a crucial role in monitoring and managing this common chemotherapy side effect.
Area of Science:
- Oncology
- Gastroenterology
- Nursing Practice
Background:
- Chemotherapy-induced diarrhea (CID) is a common and significant adverse event in cancer patients.
- CID can negatively impact patient quality of life, treatment adherence, and healthcare costs.
Purpose of the Study:
- To provide an overview of chemotherapy-induced diarrhea (CID).
- To highlight the pathophysiology, incidence, and impact of CID.
- To describe the oncology nurse's role in managing CID.
Main Methods:
- Review of primary and tertiary literature.
- Incorporation of authors' clinical experience.
Main Results:
- CID is a frequent complication across various chemotherapy regimens.
- The severity of CID can significantly affect patient outcomes and treatment delivery.
- Patients may underreport symptoms, necessitating proactive monitoring.
Conclusions:
- Vigilance from the healthcare team is essential for effective CID management.
- Oncology nurses are uniquely positioned to monitor, assess, and guide management of CID.
- Early detection and intervention by oncology nurses can improve patient care and outcomes.